Attached files

file filename
10-K - FORM 10-K - Amarantus Bioscience Holdings, Inc.v374510_10k.htm
EX-21 - EXHIBIT 21 - Amarantus Bioscience Holdings, Inc.v374510_ex21.htm
EX-32.2 - EXHIBIT 32.2 - Amarantus Bioscience Holdings, Inc.v374510_ex32-2.htm
EX-10.45 - EXHIBIT 10.45 - Amarantus Bioscience Holdings, Inc.v374510_ex10-45.htm
EX-31.2 - EXHIBIT 31.2 - Amarantus Bioscience Holdings, Inc.v374510_ex31-2.htm
EX-23.1 - EXHIBIT 23.1 - Amarantus Bioscience Holdings, Inc.v374510_ex23-1.htm
EX-31.1 - EXHIBIT 31.1 - Amarantus Bioscience Holdings, Inc.v374510_ex31-1.htm
EX-10.47 - EXHIBIT 10.47 - Amarantus Bioscience Holdings, Inc.v374510_ex10-47.htm
EX-10.48 - EXHIBIT 10.48 - Amarantus Bioscience Holdings, Inc.v374510_ex10-48.htm
EX-10.44 - EXHIBIT 10.44 - Amarantus Bioscience Holdings, Inc.v374510_ex10-44.htm
EX-23.2 - EXHIBIT 23.2 - Amarantus Bioscience Holdings, Inc.v374510_ex23-2.htm

 

EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AMARANTUS BIOSCIENCE HOLDINGS, INC.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2013
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I am the Chief Executive Officer of Amarantus Bioscience Holdings, Inc., a Nevada corporation (the “Company”). I am delivering this certificate in connection with the annual report on Form 10-K of the Company for the fiscal year ended December 31, 2013 and filed with the Securities and Exchange Commission (“Form 10-K”).

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-K fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

Date: April 21, 2014 /s/ GERALD E. COMMISSIONG
  Gerald E. Commissiong
  Chief Executive Officer